Actinogen Medical Statistics

Total Valuation

ASX:ACW has a market cap or net worth of AUD 150.18 million. The enterprise value is 143.87 million.

Market Cap	150.18M
Enterprise Value	143.87M

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:ACW has 3.58 billion shares outstanding. The number of shares has increased by 19.06% in one year.

Current Share Class	3.58B
Shares Outstanding	3.58B
Shares Change (YoY)	+19.06%
Shares Change (QoQ)	+3.62%
Owned by Insiders (%)	14.55%
Owned by Institutions (%)	4.13%
Float	2.86B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.39
PB Ratio	17.95
P/TBV Ratio	22.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.03
EV / Sales	19.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.75

Financial Position

The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.03.

Current Ratio	4.19
Quick Ratio	4.17
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-101.58

Financial Efficiency

Return on equity (ROE) is -110.77% and return on invested capital (ROIC) is -70.01%.

Return on Equity (ROE)	-110.77%
Return on Assets (ROA)	-63.83%
Return on Invested Capital (ROIC)	-70.01%
Return on Capital Employed (ROCE)	-216.19%
Weighted Average Cost of Capital (WACC)	9.30%
Revenue Per Employee	1.23M
Profits Per Employee	-2.99M
Employee Count	6
Asset Turnover	0.41
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.48% in the last 52 weeks. The beta is 0.90, so ASX:ACW's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	+35.48%
50-Day Moving Average	0.05
200-Day Moving Average	0.04
Relative Strength Index (RSI)	43.71
Average Volume (20 Days)	3,415,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ACW had revenue of AUD 7.36 million and -17.91 million in losses. Loss per share was -0.01.

Revenue	7.36M
Gross Profit	7.36M
Operating Income	-18.40M
Pretax Income	-17.91M
Net Income	-17.91M
EBITDA	-18.05M
EBIT	-18.40M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 6.53 million in cash and 223,889 in debt, giving a net cash position of 6.31 million or 0.00 per share.

Cash & Cash Equivalents	6.53M
Total Debt	223,889
Net Cash	6.31M
Net Cash Per Share	0.00
Equity (Book Value)	8.37M
Book Value Per Share	0.00
Working Capital	6.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.41 million and capital expenditures -38,373, giving a free cash flow of -16.45 million.

Operating Cash Flow	-16.41M
Capital Expenditures	-38,373
Free Cash Flow	-16.45M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -249.87% and -243.22%.

Gross Margin	100.00%
Operating Margin	-249.87%
Pretax Margin	-243.22%
Profit Margin	-243.22%
EBITDA Margin	-245.12%
EBIT Margin	-249.87%
FCF Margin	n/a

Dividends & Yields

ASX:ACW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.06%
Shareholder Yield	-19.06%
Earnings Yield	-11.93%
FCF Yield	-10.95%

Stock Splits

The last stock split was on December 3, 2013. It was a reverse split with a ratio of 0.5.

Last Split Date	Dec 3, 2013
Split Type	Reverse
Split Ratio	0.5

Scores

ASX:ACW has an Altman Z-Score of 8.82 and a Piotroski F-Score of 3.

Altman Z-Score	8.82
Piotroski F-Score	3